- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Biochemistry Research International
Volume 2011 (2011), Article ID 285618, 5 pages
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes
1Laboratory of Physiology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece
2Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece
3Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece
Received 19 April 2011; Revised 4 July 2011; Accepted 23 July 2011
Academic Editor: Tzi-Bunb Ng
Copyright © 2011 Christos S. Derdemezis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. G. Kopelman, “Obesity as a medical problem,” Nature, vol. 404, no. 6778, pp. 635–643, 2000.
- L. F. Van Gaal, I. L. Mertens, and C. E. De Block, “Mechanisms linking obesity with cardiovascular disease,” Nature, vol. 444, no. 7121, pp. 875–880, 2006.
- D. C. W. Lau, B. Dhillon, H. Yan, P. E. Szmitko, and S. Verma, “Adipokines: molecular links between obesity and atheroslcerosis,” The American Journal of Physiology, vol. 288, no. 5, pp. H2031–H2041, 2005.
- T. D. Filippatos, C. S. Derdemezis, D. N. Kiortsis, A. D. Tselepis, and M. S. Elisaf, “Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome,” Journal of Endocrinological Investigation, vol. 30, no. 4, pp. 323–326, 2007.
- T. D. Filippatos, H. S. Randeva, C. S. Derdemezis, M. S. Elisaf, and D. P. Mikhailidis, “Visfatin/PBEF and atherosclerosis-related diseases,” Current Vascular Pharmacology, vol. 8, no. 1, pp. 12–28, 2010.
- M. G. L. Hertog, D. Kromhout, C. Aravanis et al., “Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study,” Archives of Internal Medicine, vol. 155, no. 4, pp. 381–386, 1995.
- M. Monagas, N. Khan, C. Andres-Lacueva et al., “Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease,” The American Journal of Clinical Nutrition, vol. 90, no. 5, pp. 1144–1150, 2009.
- L. A. E. Hughes, I. C. W. Arts, T. Ambergen et al., “Higher dietary flavone, flavonol, and catechin intakes are associated with less of an increase in BMI over time in women: a longitudinal analysis from the Netherlands Cohort Study,” The American Journal of Clinical Nutrition, vol. 88, no. 5, pp. 1341–1352, 2008.
- M. Bose, J. D. Lambert, J. Ju, K. R. Reuhl, S. A. Shapses, and C. S. Yang, “The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat—fed mice,” The Journal of Nutrition, vol. 138, no. 9, pp. 1677–1683, 2008.
- L. K. Stewart, J. L. Soileau, D. Ribnicky et al., “Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet,” Metabolism, vol. 57, no. 1, pp. S39–S46, 2008.
- L. Rivera, R. Moron, M. Sanchez, A. Zarzuelo, and M. Galisteo, “Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats,” Obesity, vol. 16, no. 9, pp. 2081–2087, 2008.
- A. Basu, K. Sanchez, M. J. Leyva et al., “Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome,” Journal of the American College of Nutrition, vol. 29, no. 1, pp. 31–40, 2010.
- H. Wang, Y. Wen, Y. Du et al., “Effects of catechin enriched green tea on body composition,” Obesity, vol. 18, no. 4, pp. 773–779, 2010.
- M. Wabitsch, R. E. Brenner, I. Melzner, et al., “Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation,” International Journal of Obesity, vol. 25, no. 1, pp. 8–15, 2001.
- J. L. Ramirez-Zacarias, F. Castro-Munozledo, and W. Kuri-Harcuch, “Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O,” Histochemistry, vol. 97, no. 6, pp. 493–497, 1992.
- P. Fossati and L. Prencipe, “Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide,” Clinical Chemistry, vol. 28, no. 10, pp. 2077–2080, 1982.
- O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951.
- K. A. Grove and J. D. Lambert, “Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity,” The Journal of Nutrition, vol. 140, no. 3, pp. 446–453, 2010.
- V. R. Ramprasath and P. J. H. Jones, “Anti-atherogenic effects of resveratrol,” European Journal of Clinical Nutrition, vol. 64, no. 7, pp. 660–668, 2010.
- C. L. Hsu and G. C. Yen, “Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms,” Molecular Nutrition and Food Research, vol. 52, no. 1, pp. 53–61, 2008.
- P. Wang, E. Mariman, J. Renes, and J. Keijer, “The secretory function of adipocytes in the physiology of white adipose tissue,” Journal of Cellular Physiology, vol. 216, no. 1, pp. 3–13, 2008.
- J. R. Revollo, A. Korner, K. F. Mills et al., “Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme,” Cell Metabolism, vol. 6, no. 5, pp. 363–375, 2007.
- C. C. Chuang, K. Martinez, G. Xie, et al., “Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-α-mediated inflammation and insulin resistance in primary human adipocytes,” The American Journal of Clinical Nutrition, vol. 92, no. 6, pp. 1511–1521, 2010.
- A. W. Harmon and J. B. Harp, “Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis,” The American Journal of Physiology, vol. 280, no. 4, pp. C807–C813, 2001.
- S. Y. Cho, P. J. Park, H. J. Shin, et al., “(-)-catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells,” The American Journal of Physiology, vol. 292, no. 4, pp. E1166–E1172, 2007.
- T. Tsuda, Y. Ueno, H. Aoki et al., “Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes,” Biochemical and Biophysical Research Communications, vol. 316, no. 1, pp. 149–157, 2004.
- N. Chen, R. Bezzina, E. Hinch et al., “Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet,” Nutrition Research, vol. 29, no. 11, pp. 784–793, 2009.
- S. Wein, N. Behm, R. K. Petersen, K. Kristiansen, and S. Wolffram, “Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism,” European Journal of Pharmaceutical Sciences, vol. 41, no. 1, pp. 16–22, 2010.
- K. Décordé, P. L. Teissèdre, T. Sutra, E. Ventura, J. P. Cristol, and J. M. Rouanet, “Chardonnay grape seed procyanidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers,” Molecular Nutrition and Food Research, vol. 53, no. 5, pp. 659–666, 2009.
- Y. H. Kao, R. A. Hiipakka, and S. Liao, “Modulation of endocrine systems and food intake by green tea epigallocatechin gallate,” Endocrinology, vol. 141, no. 3, pp. 980–987, 2000.
- M. Shimada, K. Mochizuki, N. Sakurai, and T. Goda, “Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats,” Bioscience, Biotechnology and Biochemistry, vol. 71, no. 8, pp. 2079–2082, 2007.
- C. S. Costa, F. Rohden, T. O. Hammes et al., “Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARγ1–3 mRNA expression in human visceral adipocytes,” Obesity Surgery, vol. 21, no. 3, pp. 356–361, 2010.
- G. C. Bakker, M. J. van Erk, L. Pellis et al., “An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach,” The American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 1044–1059, 2010.